Such genome-wide gene-expression studies with human MCL cell lines differing in their sensitivity to BTK inhibition indicated that the inhibition impairs glycolysis, glutaminolysis, pentose shunt, TCA cycle, and phospholipid metabolism. Here, BTK is linked to mantle cell lymphoma.